Lisa H Butterfield

29PUBLICATIONS
141CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyInnate immunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Dec 10, 2025
Serum Arginase-1 is a predictive biomarker for melanoma patients and a surrogate indicator of systemic myeloid cell fitness.

Matthias Brand, Juraj Adamik, Hong Wang

|Dec 09, 2025
Advances in the development of personalized neoantigen therapies.

Spencer E Mirabile-Brightman, Lisa H Butterfield

|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma.

Ahmad A Tarhini, Alyssa Obermayer, Sandra J Lee

|May 12, 2025
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study.

Zoe Quandt, Anastasia Lucas, Samantha I Liang

|Aug 27, 2024
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.

Apostolia M Tsimberidou, Farah A Alayli, Kwame Okrah

|Feb 10, 2024
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond.

Surya Pandey, Meghan E Cholak, Rishita Yadali

Pageof 5

Frequent Collaborators

5 joint publications

John M Kirkwood

4 joint publications

Walter J Storkus

3 joint publications

Sean C Bendall

3 joint publications

F Stephen Hodi